1607 Capital Partners’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.79M Sell
442,213
-72,260
-14% -$1.04M 0.59% 46
2026
Q1
$7.39M Buy
+514,473
New +$7.64M 0.53% 46
2025
Q2
Sell
-759,827
Closed -$11.3M 121
2025
Q1
$11.3M Sell
759,827
-42,852
-5% -$671K 0.91% 33
2024
Q4
$11.6M Sell
802,679
-235,179
-23% -$3.64M 0.93% 35
2024
Q3
$16.4M Sell
1,037,858
-140,642
-12% -$2.22M 1.5% 15
2024
Q2
$18.1M Sell
1,178,500
-164,265
-12% -$2.49M 1.62% 15
2024
Q1
$22M Sell
1,342,765
-215,566
-14% -$3.4M 1.79% 9
2023
Q4
$22.8M Sell
1,558,331
-15,450
-1% -$216K 1.6% 13
2023
Q3
$22.7M Sell
1,573,781
-8,300
-0.5% -$129K 1.7% 12
2023
Q2
$26M Buy
1,582,081
+9,855
+0.6% +$161K 1.86% 11
2023
Q1
$26.3M Buy
1,572,226
+56,861
+4% +$916K 1.85% 11
2022
Q4
$23.4M Buy
1,515,365
+479,689
+46% +$7.43M 1.61% 17
2022
Q3
$15.5M Buy
1,035,676
+199,594
+24% +$3.3M 1.2% 26
2022
Q2
$13.7M Buy
836,082
+478,058
+134% +$8.2M 0.94% 31
2022
Q1
$7.18M Buy
358,024
+120,947
+51% +$2.51M 0.42% 57
2021
Q4
$6.01M Buy
237,077
+13,410
+6% +$346K 0.32% 59
2021
Q3
$6.04M Sell
223,667
-113,866
-34% -$3.26M 0.3% 58
2021
Q2
$9.76M Sell
337,533
-86,392
-20% -$2.39M 0.47% 51
2021
Q1
$11.1M Buy
+423,925
New +$12M 0.54% 50

Other funds holding BMEZ

1607 Capital Partners's BMEZ Position: Q2 2026 in Review

1607 Capital Partners reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 14% in Q2 2026, selling an estimated $1.04M and leaving 442,213 shares worth $6.79M. The position accounts for 0.59% of the portfolio, ranked #46.

1607 Capital Partners first reported a position in BMEZ in Q1 2021 and has held it in 19 quarters since. The position peaked at $26.3M in Q1 2023. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • 1607 Capital Partners held 442,213 shares of BlackRock Health Sciences Trust II worth $6.79M as of Q2 2026.
  • 1607 Capital Partners sold 72,260 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $1.04M.
  • BlackRock Health Sciences Trust II made up 0.59% of 1607 Capital Partners's portfolio in Q2 2026, its #46 holding.
  • 1607 Capital Partners first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and has held it in 19 quarters since.
  • 1607 Capital Partners's BlackRock Health Sciences Trust II position peaked at $26.3M in Q1 2023.
  • 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on 1607 Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.